Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial-Reference-Cited by-同舟云学术

Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial

Published:2023-09 Issue:9 Volume:10 Page:e566-e577
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Ramgopal Moti N,Castagna Antonella,Cazanave Charles,Diaz-Brito Vicens,Dretler Robin,Oka Shinichi,Osiyemi Olayemi,Walmsley Sharon,Sims James,Di Perri Giovanni,Sutton Kenneth,Sutherland-Phillips Denise,Berni Alessandro,Latham Christine L,Zhang Feifan,D'Amico Ronald,Pascual Bernáldez Miguel,Van Solingen-Ristea Rodica,Van Eygen Veerle,Patel Parul,Chounta Vasiliki,Spreen William R,Garges Harmony P,Smith Kimberly,van Wyk Jean

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference26 articles.

1. The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11;Lesko;Int J Epidemiol,2016

2. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society—USA Panel;Saag;JAMA,2020

3. Adherence to HIV treatment regimens: systematic literature review and meta-analysis;Altice;Patient Prefer Adherence,2019

4. Experiences and emotional challenges of antiretroviral treatment (ART)—findings from the positive perspectives study;De Los Rios;Open Forum Infect Dis,2019

5. Beyond viral suppression of HIV—the new quality of life frontier;Lazarus;BMC Med,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine;Journal of Antimicrobial Chemotherapy;2024-07-27

2. Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability;Clinical Infectious Diseases;2024-07-11

3. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

4. One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study;Open Forum Infectious Diseases;2024-06-20

5. Clinical considerations when switching antiretroviral therapy;Expert Review of Clinical Pharmacology;2024-06-17